Research Site 22 is a clinical research site located in Beavercreek, Ohio, United States 45431.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
Research Site 22 has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Hypertriglyceridemia.
Sponsors: Arrowhead Pharmaceuticals.
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Research Site 22 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Research Site 22 has 1 clinical trials on record, with 1 currently active. Their work covers Hypertriglyceridemia.
Research Site 22 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.